2023-08-02 08:29:30 ET
- Fresenius Medical Care press release ( NYSE: FMS ): Q2 GAAP EPS of ?0.48.
- Revenue of ?4.83B (+1.5% Y/Y).
- Care Delivery revenue increased by 1% to EUR 3,873 million (+6% at constant currency, +6% organic).
- Care Enablement revenue remained stable and amounted to EUR 1,325 million (+6% at constant currency, +6% organic).
- Operating income increased by 5% to EUR 357 million (+5% at constant currency), resulting in a margin of 7.4% (Q2 2022: 7.2%).
- Net income decreased by 5% to EUR 140 million (-4% at constant currency). Excluding special items and PRF1, net income increased by 51% to EUR 175 million (+54% at constant currency).
- In the second quarter, Fresenius Medical Care generated EUR 1,007 million of operating cash flow (Q2 2022: EUR 751 million), resulting in a margin of 20.9% (Q2 2022: 15.8%).
For further details see:
Fresenius Medical Care GAAP EPS of ?0.48, revenue of ?4.83B